Viridian Therapeutics to Webcast VRDN-001 Phase 3 THRIVE Topline Results on September 10, 2024
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky weekÂ
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: VRDN) | Delayed: 22.50 -0.32 (1.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.82 | 52 Week High | $ | |||
| Open | $22.75 | 52 Week Low | $ | |||
| Day High | $22.75 | P/E | N/A | |||
| Day Low | $21.92 | EPS | $ | |||
| Volume | 601,809 | |||||
